Telomir Pharmaceuticals Inc（TELO）價格預測TELOTelomir Pharmaceuticals Inc

Alphio's TELO stock price prediction model matches the current Telomir Pharmaceuticals Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.12 (-0.17%). The 1-week path is $1.11 (-0.64%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Telomir Pharmaceuticals Inc (TELO) is currently trading at $1.14, which is below its 200-day simple moving average of $1.279. The stock has a relative strength index (RSI) of 46.462, indicating it is neither overbought nor oversold. However, the company has reported consistent losses, with a net income of -$47,835,431 in Q2 2026 and a negative EPS of -0.79. The forward P/E ratio is 0, indicating no earnings expected in the near term. The stock has seen a year-to-date change of -14.93%, suggesting a downward trend. The main risk is the significant net loss reported, which could impact future performance. Overall, while there are some signs of potential recovery, the current financial performance and negative earnings trend suggest it may be prudent to hold off on buying until further positive developments occur.

Telomir Pharmaceuticals Inc (TELO) last closed at $1.12, gaining +1.82%. These facts feed the 1-day and 1-week TELO price prediction above.